课题基金 / 基金详情

3D Probabilistic Profiles of Protein/Peptide Interactions

3D Probabilistic Profiles of Protein/Peptide Interactions
蛋白质/肽相互作用的 3D 概率图
批准号:
7051878
负责人:
RICHARD Masten FINE
金额:
$10.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2008-05-31

项目摘要

项目成果

RICHARD Masten FINE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):多肽在许多生理过程中起决定性作用,因此在疫苗和多肽、多肽类药物和小分子药物的开发中发挥着越来越大的作用。由于功能和结构-基因组数据的爆炸性增长,迫切需要新的方法来分析和预测多肽-蛋白质相互作用,以便将这些数据有效地提取到药物和疫苗中。在这个提案中,我们描述了一种新的解决方案,通过开发一种新的方法来描述和预测结构解析的蛋白质的肽-蛋白质相互作用(MRF)。MRF的自由能最小化产生了称为3D概率多肽轮廓或3D轮廓的概率分布。3D图谱概率地指定了活性部位内氨基酸的类型、位置、取向和构象,这些活性部位可以连接以形成能量有利的、最好是较长的多肽链。然后,3D图谱可用于(A)识别将结合的多肽,或(B)生成用于测试的优化的多肽组合文库。MRF模型包含了详细的能量信息,并可以包含关于目标系统的先验知识,包括(I)已知结合的多肽序列;(Ii)结构确定的肽/蛋白质复合体;(Iii)蛋白质活性位点突变信息;以及(Iv)核磁共振衍生的距离限制。可以组合多个MRF模型来考虑蛋白质的灵活性。MRF模型是通过将氨基酸探针初始定位到活性部位的精细网格中来创建的。快速信念传播方法通过优化特定活性位点位置上特定氨基酸的信念,同时调整它们的位置和方向,从而最小化内部MRF自由能。最终的多肽构象和文库是通过对图谱进行边际化而获得的。MRF方法是新颖的,与现有的将单个多肽对接到靶标的方法相比,具有显著的原则性优势。实现了一个健壮的软件原型,并给出了一个PDZ域的初步结果。在第一阶段,我们将完成原型并将其应用于sh2/sh3域、PDZ域和MHC L/ll域。在第二阶段,我们将优化和利用方法来解决制药和生物防御方面的问题,其中可能包括开发底物竞争性抑制剂来抑制YopH酶或YopH的抑制剂,YopH是一种鼠疫耶尔森氏菌蛋白酪氨酸磷酸酶。
英文摘要
DESCRIPTION (provided by applicant): Peptides play a decisive role in many physiological processes and as a result are playing an increasing role in the development of vaccines and peptide, peptidomimetic, and small-molecule drugs. Because of an explosion of functional and structural-genomic data, there is an urgent need for new methods to analyze and predict peptide-protein interactions, to allow this data to be effectively distilled into drugs and vaccines. In this proposal, we describe a new solution to this problem, through development of a new approach to describe and predict peptide-protein interactions for structurally solved proteins using Markov Random Fields (MRF). Free energy minimization of the MRF yields a probability distribution called a 3D probabilistic peptide profile or 3D profile. The 3D profile probabilistically specifies types, locations, orientations, and conformations of amino acids within active sites that can be connected to form energetically favorable, preferably long, polypeptide chains. 3D profiles can then be used to (a) recognize peptides that will bind, or to (b) generate optimized combinatorial libraries of peptides for testing. MRF models incorporate detailed energetic information and can incorporate prior knowledge on the target system including (i) sequences of peptides known to bind; (ii) structurally determined peptide/protein complexes; (iii) protein active site mutagenic information; and (iv) NMR-derived distance constraints. Multiple MRF models can be combined to account for protein flexibility. MRF models are created by initially positioning amino-acid probes into a fine grid in the active site. Fast Belief Propagation methods then minimize the internal MRF free energy, by optimizing beliefs for specific amino acids at specific active site positions while adjusting their positions and orientations. Final peptide conformations and libraries are obtained by marginalizing the profile. The MRF approach is novel and has significant principled advantages over existing methods that docking individual peptides to a target. A robust software prototype has been implemented; initial results are given for a PDZ domain. In Phase I, we will complete the prototype and apply it to SH2/SH3 domains, PDZ domains, and MHC l/ll domains. In Phase II, we will optimize and utilize the methods to tackle problems of pharmaceutical and biodefense interest that may include development of substrate-competitive inhibitors to kinases or inhibitors of YopH, a Yersinia Pestis protein tyrosine phosphatase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Probabilistic Engine for Virtual Screening
  • 批准号:
    6786885
  • 项目类别:
  • 资助金额:
    $15.34万
  • 财政年份:
    2004
  • 负责人:
    RICHARD Masten FINE
  • 依托单位:
Learning Drug Specifity in Protein Families by Docking
  • 批准号:
    6798336
  • 项目类别:
  • 资助金额:
    $46.33万
  • 财政年份:
    2000
  • 负责人:
    RICHARD Masten FINE
  • 依托单位:
Learning Drug Specificity in Protein Families by Docking
  • 批准号:
    6692482
  • 项目类别:
  • 资助金额:
    $50.18万
  • 财政年份:
    2000
  • 负责人:
    RICHARD Masten FINE
  • 依托单位:
LEARNING DRUG SPECIFICITY FROM PROTEIN FAMILIES
  • 批准号:
    6143503
  • 项目类别:
  • 资助金额:
    $9.79万
  • 财政年份:
    2000
  • 负责人:
    RICHARD Masten FINE
  • 依托单位:
海外基金